Topic

Aetna (CVS Health)

A collection of 1074 issues

Myths vs. Facts: Getting Synagis (Palivizumab) Covered by Aetna (CVS Health) in New Jersey

Answer Box: Fast Track to Synagis Approval in New Jersey Synagis (palivizumab) requires prior authorization from Aetna (CVS Health) with step therapy mandating Beyfortus (nirsevimab) first-line unless contraindicated. High-risk infants (<29 weeks gestation, chronic lung disease, or hemodynamically significant congenital heart disease) need specialist documentation and proof Beyfortus is

Myths vs. Facts: Getting Jynarque (tolvaptan) Covered by Aetna (CVS Health) in Texas

Answer Box: Get Jynarque Covered by Aetna in Texas Fast track to approval: Aetna (CVS Health) covers Jynarque for ADPKD with prior authorization requiring documented rapid progression (Mayo Class 1C-1E or eGFR decline ≥3.0 mL/min/1.73m²/year), nephrologist prescription, and REMS enrollment. Submit via CVS Caremark provider

How to Get Uptravi (Selexipag) Covered by Aetna (CVS Health) in Illinois: Prior Authorization Forms, Appeals Process, and Approval Timeline

Answer Box: Getting Uptravi (Selexipag) Covered by Aetna (CVS Health) in Illinois Yes, Aetna (CVS Health) covers Uptravi (selexipag) for WHO Group I pulmonary arterial hypertension with prior authorization. The fastest path: gather your right heart catheterization report, WHO functional class documentation, and 6-minute walk test results. Submit the Illinois-specific

Myths vs. Facts: Getting Breyanzi (lisocabtagene maraleucel) Covered by Aetna (CVS Health) in Florida

Quick Answer: Aetna (CVS Health) requires prior authorization for Breyanzi (lisocabtagene maraleucel) under Clinical Policy Bulletin #986, covering FDA-approved B-cell lymphoma indications for patients ≥18 with ECOG ≤2 after documented treatment failures. Submit PA via Availity portal or fax 1-877-269-9916 with complete clinical documentation. If denied, file internal appeal within

How to Get Vanflyta (Quizartinib) Covered by Aetna CVS Health in Illinois: Complete Approval Timeline and Appeals Guide

Answer Box: Getting Vanflyta Covered by Aetna CVS Health in Illinois Vanflyta (quizartinib) requires prior authorization from Aetna CVS Health for FLT3-ITD-positive AML, with approval typically taking 30-45 days for standard review or ≤72 hours if expedited. Key requirements: FLT3-ITD mutation documentation, baseline EKG showing QTc ≤450ms, and hematologist prescription.

How to Get Pemazyre (pemigatinib) Covered by Aetna (CVS Health) in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Pemazyre Covered in Pennsylvania Pemazyre (pemigatinib) requires prior authorization from Aetna CVS Health for FGFR2 fusion-positive cholangiocarcinoma. In Pennsylvania, you have strong appeal rights including a new state external review program with 50%+ overturn rates. First step today: Have your oncologist submit PA via Aetna's

How to Get Pyrukynd (mitapivat) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Your Fastest Path to Pyrukynd Coverage Getting Pyrukynd (mitapivat) covered by Aetna CVS Health in Pennsylvania requires prior authorization through CVS Caremark. Most approvals happen within 24-72 hours when clinical criteria are met. First step today: Have your hematologist gather genetic confirmation of pyruvate kinase deficiency, baseline labs

Getting Signifor LAR (Pasireotide) Approved by Aetna in Virginia: Prior Authorization Guide and Appeal Process

Answer Box: Fast Track to Approval To get Signifor LAR (pasireotide) covered by Aetna in Virginia: Submit prior authorization with documented trial/failure of Somatuline Depot (lanreotide), elevated IGF-1 or cortisol labs, and surgical history via Aetna's precertification form. Appeals must be filed within 180 days, with Virginia

How to Get Strimvelis Gene Therapy Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Get Strimvelis Covered by Aetna CVS Health in Illinois Strimvelis gene therapy for ADA-SCID requires prior authorization from Aetna CVS Health with genetic confirmation of biallelic ADA mutations, enzyme activity <1% normal, and documented failures of PEG-ADA therapy. Submit through the Aetna provider portal with a medical

The Requirements Checklist to Get Kuvan (Sapropterin) Covered by Aetna CVS Health in Michigan

Answer Box: Getting Kuvan Covered by Aetna CVS Health in Michigan Aetna CVS Health requires prior authorization for Kuvan (sapropterin) in PKU patients with phenylalanine levels ≥360 μmol/L (6 mg/dL) despite dietary management. You'll need confirmed PKU diagnosis, documented BH4 responsiveness (≥20% phenylalanine reduction), and specialist